41
42
Meijboom, M. J., Rozenbaum, M. H., Benedictus, A., Luytjes, W., Kneyber, M. C. J., Wilschut, J. C., Hak, E., Postma, M. J.
Veröffentlicht in: Meijboom , M J , Rozenbaum , M H , Benedictus , A , Luytjes , W , Kneyber , M C J , Wilschut , J C , Hak , E & Postma , M J 2012 , ' Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands ' , Vaccine , vol. 30 , no. 31 , pp. 4691-4700 . https://doi.org/10.1016/j.vaccine.2012.04.072;
2012
Veröffentlicht in: Meijboom , M J , Rozenbaum , M H , Benedictus , A , Luytjes , W , Kneyber , M C J , Wilschut , J C , Hak , E & Postma , M J 2012 , ' Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands ' , Vaccine , vol. 30 , no. 31 , pp. 4691-4700 . https://doi.org/10.1016/j.vaccine.2012.04.072;
2012
43
Jacobs, M S, van Leent, M W J, Tieleman, R G, Jansman, F G A, Cao, Q, Postma, M J, van Hulst, M
Veröffentlicht in: Jacobs , M S , van Leent , M W J , Tieleman , R G , Jansman , F G A , Cao , Q , Postma , M J & van Hulst , M 2017 , ' Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 12 , pp. 1231-1236 . https://doi.org/10.1080/13696998.2017.1363766;
2017
Veröffentlicht in: Jacobs , M S , van Leent , M W J , Tieleman , R G , Jansman , F G A , Cao , Q , Postma , M J & van Hulst , M 2017 , ' Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 12 , pp. 1231-1236 . https://doi.org/10.1080/13696998.2017.1363766;
2017
44
Eijsink, J.F.H., Schöttler, M.H., Al Khayat, M.N.M.T., de Groot, J.W.B., Boersma, C., Postma, M.J.
Veröffentlicht in: Value in Health ; volume 23, page S422 ; ISSN 1098-3015;
2020
Veröffentlicht in: Value in Health ; volume 23, page S422 ; ISSN 1098-3015;
2020
45
46
de Vries, R., Kretzschmar, M., Schellekens, J.F.P., Versteegh, F.G.A., Westra, T.A., Roord, J.J., Postma, M.J.
Veröffentlicht in: de Vries , R , Kretzschmar , M , Schellekens , J F P , Versteegh , F G A , Westra , T A , Roord , J J & Postma , M J 2010 , ' Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands: Using an Individual-Based Dynamic Model ' , PLoS ONE , vol. 5 , no. 10 , pp. 1-11 . https://doi.org/10.1371/journal.pone.0013392;
2010
Veröffentlicht in: de Vries , R , Kretzschmar , M , Schellekens , J F P , Versteegh , F G A , Westra , T A , Roord , J J & Postma , M J 2010 , ' Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands: Using an Individual-Based Dynamic Model ' , PLoS ONE , vol. 5 , no. 10 , pp. 1-11 . https://doi.org/10.1371/journal.pone.0013392;
2010
47
48
de Jong, L.A., Koops, M., Gout-Zwart, J.J., Beinema, M.J., Hemels, M.E.W., Postma, M.J., Brouwers, J.R.B.J.
Veröffentlicht in: de Jong , L A , Koops , M , Gout-Zwart , J J , Beinema , M J , Hemels , M E W , Postma , M J & Brouwers , J R B J 2018 , ' Trends in direct oral anticoagulant (DOAC) use : Health benefits and patient preference ' , Netherlands Journal of Medicine , vol. 76 , no. 10 , pp. 426-430 .;
2018
Veröffentlicht in: de Jong , L A , Koops , M , Gout-Zwart , J J , Beinema , M J , Hemels , M E W , Postma , M J & Brouwers , J R B J 2018 , ' Trends in direct oral anticoagulant (DOAC) use : Health benefits and patient preference ' , Netherlands Journal of Medicine , vol. 76 , no. 10 , pp. 426-430 .;
2018
49
50
Assink, M.D., Kiewiet, J.P., Rozenbaum, M.H., van den Berg, P.B., Hak, E., Buskens, E.J., Wilschut, J.C., Kroes, A.C., Postma, M.J.
Veröffentlicht in: Assink , M D , Kiewiet , J P , Rozenbaum , M H , van den Berg , P B , Hak , E , Buskens , E J , Wilschut , J C , Kroes , A C & Postma , M J 2009 , ' Excess drug prescriptions during influenza and RSV seasons in the Netherlands : Potential implications for extended influenza vaccination ' , Vaccine , vol. 27 , no. 7 , pp. 1119-1126 . https://doi.org/10.1016/j.vaccine.2008.11.070;
2009
Veröffentlicht in: Assink , M D , Kiewiet , J P , Rozenbaum , M H , van den Berg , P B , Hak , E , Buskens , E J , Wilschut , J C , Kroes , A C & Postma , M J 2009 , ' Excess drug prescriptions during influenza and RSV seasons in the Netherlands : Potential implications for extended influenza vaccination ' , Vaccine , vol. 27 , no. 7 , pp. 1119-1126 . https://doi.org/10.1016/j.vaccine.2008.11.070;
2009